閉塞性動脈硬化症のゲノムワイド関連解析

学位の種別: 課程博士審査委員会委員 : （主査）東京大学教授 南學 正臣, 東京大学准教授 山内 敏正, 東京大学准教授 福原 浩, 東京大学准教授 平田 康隆, 東京大学講師 石原 聡一郎University of Tokyo(東京大学

Cross-talk between TLR3 and TNF-α or IFN-γ Signaling in Induction of CXCL8/IL-8 and CXCL10/IP-10 Expression in Airway Epithelial Cells

CXCL8/IL-8 is a chemoattractant for neutrophils and mast cells, and regulates inflammatory cell recruitment in allergy, infection, and other neutrophil-related diseases. Interferon (IFN) -γ-inducible protein 10 (CXCL10/IP-10) is a chemokine that attracts mononuclear cells, Th1 cells, and natural killer cells. We investigated the levels of CXCL8/IL-8 and CXCL10/IP-10 expression by airway epithelial cells after exposure to the inflammatory cytokines tumor necrosis factor (TNF) -α and IFN-γ, and to poly I:C, a synthetic analog of double-stranded RNA that is a ligand of Toll-like receptor 3 (TLR3). Poly I:C, TNF-α, IFN-γ, and combinations of poly I:C with TNF-α or IFN-γ were used to stimulate the airway epithelial cell line BEAS-2B. Following stimulation, we determined CXCL8/IL-8 and CXCL10/IP-10 mRNA levels by real-time PCR and protein levels by ELISA. Poly I:C treatment upregulated mRNA and protein expression for both CXCL8/IL-8 and CXCL10/IP-10. The addition of TNF-α, but not IFN-γ, to poly I:C further increased the expression of CXCL8/IL-8 mRNA and protein. The addition of either TNF-α or IFN-γ to the poly I:C treatment further increased CXCL10/IP-10 mRNA and protein expression. Cross-talk between TLR3 signaling and inflammatory cytokines regulates the expression of CXCL8/IL-8 and CXCL10/IP-10 in airway epithelial cells. From our results, TNF-α and IFN-γ produce different effects on TLR3 signaling

Anti-IgE therapy for allergic bronchopulmonary aspergillosis

Allergic bronchopulmonary aspergillosis (ABPA) is a severe type of asthma. Some cases are resistant to treatment, even with regular use of antiasthmatic drugs and antifungal agents. The diagnosis of ABPA was made in a 40-year-old patient with ABPA according to the Rosenberg-Patterson criteria. Symptoms were not controlled despite regular use of antiasthmatic drugs, daily systemic steroids, and antifungal agents. Omalizumab, administered in an attempt to stabilize these uncontrolled symptoms, was effective with no adverse events. Our experience suggests omalizumab is a potential candidate drug for controlling steroid-dependent ABPA

Expression of ICAM-1 on human bronchial epithelial cells after influenza virus infection

Damage of bronchial epithelium is a feature of airway viral infection and airway inflammatory disease, such as bronchial asthma. Adhesion molecules, which are expressed on bronchial epithelium, play an important role in the pathogenesis of epithelial damage and airway inflammation. We analysed ICAM-1 and VCAM-1 expression on human bronchial epithelial cell line, NCI-H292, after influenza virus A infection. ICAM-1 was expressed on control cells constitutively. Influenza virus A infection caused a three-fold increase in ICAM-1 expression on NCI-H292 cells. Supernatant of virus-infected cells was analysed for the concentration of IL-1β and TNF-α but these cytokines were not detected. VCAM-1 was not expressed on control cells and did not change after cytokine stimulation or virus infection. These findings suggest that influenza virus infection may induce ICAM-1 expression on bronchial epithelium without intervention of leukocytes, and ICAM-1 expressed on epithelium plays a major part in the pathophysiology of airway inflammatory disease caused by viral infection

Equine pericardial roll graft replacement of infected pseudoaneurysm of the ascending aorta

Abstract The standard procedure for treating infected aortic aneurysms is to resect the infected aorta, debridement of the surrounding tissue, in situ graft replacement, and omentopexy. However, the question of which graft material is optimal is still a matter of controversy. We recently treated a patient with an infected ascending aortic aneurysm. Because of previous abdominal surgery, the omentum was unavailable. The ascending aorta was replaced in situ with equine pericardial roll grafts. The patient is alive and well 29 months after the operation.</p